Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

ACCORD-2 Phase 3 trial in Alzheimer’s disease agitation achieves primary endpoint compared to placebo (p=0.001, time to relapse)ACCORD-2 Phase 3 ...

Axsome Therapeutics (AXSM) announced this morning that while the ACCORD-2 Phase 3 trial achieved the primary endpoint with AXS-05 statistically ...

Arizona State University and Banner Alzheimer's Institute researchers, along with their collaborators, have discovered a surprising link between a chronic gut infection caused by a common virus and ...

A promising ultrasound therapy to potentially restore brain function in people with Alzheimer's disease has been licenced to ...

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...

While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in diagnosis, treatment and risk management that have been made in 2024.

Researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have unveiled a critical mechanism that links cellular stress in the brain to the progression of Alzheimer ...

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

Lawyers for Mike Jeffries, the former CEO of Abercrombie & Fitch, have questioned his ability to stand trial in a federal sex ...